Acelyrin Inc. (SLRN)
NASDAQ: SLRN
· Real-Time Price · USD
2.27
0.00 (0.00%)
At close: May 20, 2025, 3:59 PM
Acelyrin Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
Revenue | n/a | n/a | 166K | 166K | 166K | 166K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 287K | 342K | 219K | 259K | 170K | 131K | 83K | 43K | 16K | n/a | n/a | n/a | n/a |
Gross Profit | -116K | -171K | -53K | -93K | -4K | 35K | -83K | -43K | -16K | n/a | n/a | n/a | n/a |
Operating Income | -293.34M | -316.26M | -335.66M | -375.33M | -325M | -422.06M | -525.27M | -446.24M | -418.43M | -254.68M | -46.37M | -30.97M | -16.09M |
Interest Income | 26.72M | 31.21M | 35.2M | 38.17M | 36.41M | 30.55M | 23.26M | 13.74M | 7.47M | 4.17M | 1.4M | 413K | n/a |
Pretax Income | -268.52M | -248.23M | -264.4M | -299.8M | -240.16M | -381.64M | -491.93M | -422.39M | -410.83M | -250.46M | -44.97M | -30.56M | -16.09M |
Net Income | -268.52M | -248.23M | -264.4M | -299.8M | -240.16M | -381.64M | -491.93M | -422.39M | -410.83M | -250.46M | -44.97M | -30.56M | -16.09M |
Selling & General & Admin | 59.78M | 66.81M | 75.45M | 82.98M | 79.01M | 66.18M | 60.35M | 43.38M | 32.88M | 24.05M | 8.14M | 5.26M | 3.08M |
Research & Development | 222.16M | 238.06M | 249.4M | 292.35M | 246M | 355.89M | 464.92M | 402.86M | 385.54M | 230.63M | 38.22M | 25.71M | 13M |
Other Expenses | 11.39M | 11.39M | 10.64M | -188K | -360K | -423K | -389K | -366K | -195K | -132K | 3K | -1K | n/a |
Operating Expenses | 293.34M | 316.26M | 335.66M | 375.33M | 325M | 422.06M | 525.27M | 446.24M | 418.43M | 254.68M | 46.37M | 30.97M | 16.09M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 233.48M | 316.26M | 335.66M | 375.33M | 325M | 422.06M | 525.27M | 446.24M | 418.43M | 254.68M | 46.37M | 30.97M | 16.09M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 100.68M | 99.3M | 99.84M | 99.16M | 97.91M | 97.58M | 96.87M | 65.21M | 97.2M | 19.69M | 20.44M | 20.44M | 20.44M |
Shares Outstanding (Diluted) | 100.68M | 99.3M | 99.84M | 99.16M | 97.91M | 97.58M | 96.87M | 65.21M | 97.2M | 19.7M | 20.44M | 20.44M | 20.44M |
EPS (Basic) | -2.7 | -2.51 | -2.69 | -3.07 | -2.61 | -4.07 | -13.53 | -13.36 | -13.67 | -12.64 | -2.2 | -1.5 | -0.79 |
EPS (Diluted) | -2.7 | -2.51 | -2.69 | -3.07 | -2.61 | -4.07 | -13.52 | -13.35 | -13.66 | -12.63 | -2.2 | -1.5 | -0.79 |
EBITDA | -275.48M | -298.35M | -328.92M | -379.48M | -329.25M | -426.36M | -525.21M | -430.83M | -388.15M | -224.4M | -16.09M | -16.09M | -16.09M |
EBIT | -222.09M | -304.86M | -324.85M | -375.33M | -325M | -418.68M | -521.88M | -442.86M | -415.05M | -254.68M | -46.37M | -30.97M | -16.09M |
Depreciation & Amortization | 368K | 423K | 325K | 259K | 170K | 131K | 22.89M | 38.25M | 53.11M | 69.18M | 46.37M | 30.97M | 16.09M |